Spero Therapeutics’ antibiotic pipeline is focused on areas for which the unmet medical need is greatest, the biological rationale for treatment is clear, and for which there are few approved therapies, or where the standard of care is suboptimal.
Our pipeline of anti-infective agents is one of the most unique in the industry and consists of three investigational product candidates, including:
The following table illustrates our product candidates, their status, and anticipated milestones for ongoing development.
Information as of February 5, 2021
Learn about the investment opportunity, see our upcoming events and download our latest corporate presentation.
Investment opportunities >Join a passionate team that pushes the limits in finding innovative therapies to help patients.
Career opportunities >Our strategic partnerships foster mutually beneficial alliances that advance medicine to improve patient lives.
Partnership opportunities >